Hear from Dr. Marcos De Lima (Ohio State University, USA) and Prof. Vikram Mathews (Christian Medical College Vellore, India) as they discuss their work in cell and gene therapy, challenges they face, how the CliniMACS Prodigy® Platform became an enabler for their work and an option for increasing patient access.
For access to additional interviews, further information on how your colleagues address patient need, or networking opportunities within your community, visit www.miltenyibiotec.com/lp/emp...
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.